Advanced Biomedical Research

The Fusion Multistage Synthetic Peptides as the Best Candidates for New Tuberculosis Vaccine

Letter to Editor

Authors

Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

1.
World Health Organization (WHO). Global tuberculosis report. 2015. Available from: www.who.int/about/ licensing/copyright_form/en/index.html. [Last accessed on 2017 Nov 05].  Back to cited text no. 1
    
2.
Lalvani A, Pathan AA, McShane H, Wilkinson RJ, Latif M, Conlon CP, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 2001;163:824-8.  Back to cited text no. 2
    
3.
Khademi F, Derakhshan M, Yousefi-Avarvand A, Tafaghodi M, Soleimanpour S. Multi-stage subunit vaccines against Mycobacterium tuberculosis: An alternative to the BCG vaccine or a BCG-prime boost? Expert Rev Vaccines 2018;17:31-44.  Back to cited text no. 3
    
4.
Nuttall JJ, Davies MA, Hussey GD, Eley BS. Bacillus calmette-guérin (BCG) vaccine-induced complications in children treated with highly active antiretroviral therapy. Int J Infect Dis 2008;12:e99-105.  Back to cited text no. 4
    
5.
Kaufmann SH, Hussey G, Lambert PH. New vaccines for tuberculosis. Lancet 2010;375:2110-9.  Back to cited text no. 5
    
6.
Mosavat A, Soleimanpour S, Farsiani H, Sadeghian H, Ghazvini K, Sankian M, et al. Fused Mycobacterium tuberculosis multi-stage immunogens with an fc-delivery system as a promising approach for the development of a tuberculosis vaccine. Infect Genet Evol 2016;39:163-72.  Back to cited text no. 6
    
7.
Baghani AA, Soleimanpour S, Farsiani H, Mosavat A, Yousefi M, Meshkat Z, et al. CFP10: MFcγ2 as a novel tuberculosis vaccine candidate increases immune response in mouse. Iran J Basic Med Sci 2017;20:122-30.  Back to cited text no. 7
    
8.
West NP, Thomson SA, Triccas JA, Medveczky CJ, Ramshaw IA, Britton WJ, et al. Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis. Vaccine 2011;29:7759-65.  Back to cited text no. 8
    
9.
Weinshank RL, Luster AD, Ravetch JV. Function and regulation of a murine macrophage-specific IgG fc receptor, fc gamma R-alpha. J Exp Med 1988;167:1909-25.  Back to cited text no. 9
    
10.
Ruhwald M, de Thurah L, Kuchaka D, Zaher MR, Salman AM, Abdel-Ghaffar AR, et al. Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6. Sci Rep 2017;7:45969.  Back to cited text no. 10
    
11.
Luabeya AK, Kagina BM, Tameris MD, Geldenhuys H, Hoff ST, Shi Z, et al. First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults. Vaccine 2015;33:4130-40.  Back to cited text no. 11
    
12.
Hemmati M, Seghatoleslam A, Rasti M, Ebadat S, Naghibalhossaini F, Mostafavi-Pour Z. Additive effect of recombinant Mycobacterium tuberculosis ESAT-6 protein and ESAT-6/CFP-10 fusion protein in adhesion of macrophages through fibronectin receptors. J Microbiol Immunol Infect 2016;49:249-56.  Back to cited text no. 12
    
13.
Davenne T, McShane H. Why don't we have an effective tuberculosis vaccine yet? Expert Rev Vaccines 2016;15:1009-13.  Back to cited text no. 13
    
14.
Khademi F, Taheri RA, Yousefi Avarvand A, Vaez H, Momtazi-Borojeni AA, Soleimanpour S. Are chitosan natural polymers suitable as adjuvant/delivery system for anti-tuberculosis vaccines? Microb Pathog 2018;121:218-23.  Back to cited text no. 14
    
15.
Shaw WV. Protein engineering. The design, synthesis and characterization of factitious proteins. Biochem J 1987;246:1-17.  Back to cited text no. 15
Advanced Biomedical Research
Volume 2018, August
August 2018
Pages 1-2